TABLE 2.

PCR for C. pneumoniae in the CSF of patients with clinically definite MS

PatientDiagnosisaAge (yr)GenderCSF characteristicsIgG indexbOCc bandsPCR assay results
VUMCdUSF with MOMP primere
Cell count (no. of cells/μl)Protein concn (mg/dl)Glucose concn (mg/dl)VU-MOMPTong and Sillis
1Sec MS45FNDfNDNDNDND+++
2RR MS47M444581.2+++
3RR MS26FNDNDNDNDND+++
4RR MS40M134680.6+++
5RR MS51M462541.27++++
6RR MS59F251600.6++
7RR MS48F248590.7+++
8Sec MS58M2671001.09+++
9Sec MS44F166631.15++++
10Sec MS55M035690.75+
11Sec MS42F131540.84++
12RR MS55F128480.73+
13RR MS55F237570.49++
14Sec MS61FNDNDNDNDND++
15Sec MS66F164610.58++
16RR MS32F517610.72
17Sec MS57M482640.57++++
18RR MS62M343550.07++++
  • a Abbreviations: Sec MS, secondary progressive MS; RR MS, relapsing remitting MS.

  • b IgG, immunoglobulin G.

  • c OC, oligoclonal.

  • d The total numbers of samples positive were 13 and 12 for the Vu-MOMP and Tong and Sillis primers, respectively.

  • e The total number of samples positive was 11.

  • f ND, not done.